{"id":51179,"date":"2026-06-26T11:29:09","date_gmt":"2026-06-26T09:29:09","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=51179"},"modified":"2026-06-21T09:33:51","modified_gmt":"2026-06-21T07:33:51","slug":"pinealon-a-ine-peptidy-porovnanie-s-epitalonom-semaxom-cerebrolysinom-ss-31-a-tesamorelinom","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/sk\/pinealon-a-inne-peptydy-porownanie-z-epitalon-semax-cerebrolysin-ss-31-i-tesamorelin\/","title":{"rendered":"Pinealon a in\u00e9 peptidy: Porovnanie s Epitalonom, Semaxom, Cerebrolysinom, SS-31 a Tesamorelinom"},"content":{"rendered":"

 <\/p>\n

Pinealon a in\u00e9 peptidy<\/h2>\n

S rast\u00facim z\u00e1ujmom o peptidov\u00e9 intervencie sa Pinealon \u010dasto porovn\u00e1va s nieko\u013ek\u00fdmi zn\u00e1mej\u0161\u00edmi peptidmi vr\u00e1tane Epitalonu, Semaxu, Cerebrolysinu, SS-31 a Tesamorelinu. Aj ke\u010f sa tieto zl\u00fa\u010deniny \u010dasto diskutuj\u00fa v rovnak\u00fdch kontextoch, v\u00fdrazne sa l\u00ed\u0161ia v molekul\u00e1rnej \u0161trukt\u00fare, biologick\u00fdch cie\u013eoch, navrhovan\u00fdch mechanizmoch \u00fa\u010dinku a oblastiach vedeck\u00e9ho v\u00fdskumu.<\/p>\n

Pinealon vs Epitalon<\/h3>\n

Pinealon a Epitalon s\u00fa bioregula\u010dn\u00e9 peptidy vyvinut\u00e9 Vladimirom Khavinsonom a jeho kolegami. Obidva s\u00fa \u010dasto diskutovan\u00e9 v kontexte zdrav\u00e9ho starnutia a v\u00fdskumu dlhovekosti. Napriek t\u00fdmto podobnostiam ide v\u0161ak o odli\u0161n\u00e9 molekuly. Pinealon je tripeptid zlo\u017een\u00fd z kyseliny glut\u00e1movej, kyseliny aspar\u00e1govej a argin\u00ednu (Glu-Asp-Arg; EDR), zatia\u013e \u010do Epitalon je tetrapeptid zlo\u017een\u00fd z alan\u00ednu, kyseliny glut\u00e1movej, kyseliny aspar\u00e1govej a glyc\u00ednu (Ala-Glu-Asp-Gly) (1,2).<\/p>\n

V\u00fdskum Pinealonu sa prim\u00e1rne zameral na neuroprotekciu, kognit\u00edvne funkcie, regul\u00e1ciu oxida\u010dn\u00e9ho stresu, pre\u017eitie neur\u00f3nov a neurologick\u00e9 zmeny s\u00favisiace s vekom (3\u20138). Experiment\u00e1lne \u0161t\u00fadie uk\u00e1zali, \u017ee Pinealon zni\u017euje hladinu reakt\u00edvnych foriem kysl\u00edka (ROS), zlep\u0161uje \u017eivotaschopnos\u0165 neur\u00f3nov, zvy\u0161uje expresiu s\u00e9roton\u00ednu a chr\u00e1ni nervov\u00e9 bunky pred r\u00f4znymi formami bunkov\u00e9ho stresu (4\u20138).<\/p>\n

Zatia\u013e \u010do v\u00fdskum Epitalonu sa zameriava predov\u0161etk\u00fdm na biol\u00f3giu starnutia, aktivitu telomer\u00e1zy, regul\u00e1ciu melaton\u00ednu, fungovanie cirkadi\u00e1nneho rytmu a mechanizmy s\u00favisiace s dlhovekos\u0165ou. Hoci oba peptidy s\u00fa klasifikovan\u00e9 ako geroprotekt\u00edvne bioregula\u010dn\u00e9 l\u00e1tky, Pinealon je zvy\u010dajne vn\u00edman\u00fd ako peptid s viac neurocentrick\u00fdm \u00fa\u010dinkom, zatia\u013e \u010do Epitalon je \u010dastej\u0161ie sp\u00e1jan\u00fd s celkov\u00fdmi protistarn\u00facimi \u0161t\u00fadiami a funkciou epif\u00fdzy.<\/p>\n

Preto\u017ee oba peptidy m\u00f4\u017eu p\u00f4sobi\u0165 na odli\u0161n\u00e9 biologick\u00e9 dr\u00e1hy, niektor\u00ed v\u00fdskumn\u00edci a u\u017e\u00edvatelia peptidov pova\u017euj\u00fa Pinealon a Epitalon za potenci\u00e1lne komplement\u00e1rne zl\u00fa\u010deniny. Kontrolovan\u00e9 klinick\u00e9 \u0161t\u00fadie hodnotia ich s\u00fa\u010dasn\u00e9 u\u017e\u00edvanie s\u00fa v\u0161ak ve\u013emi obmedzen\u00e9 a doteraz sa nevykonali rozsiahle \u0161t\u00fadie na \u013eu\u010foch potvrdzuj\u00face bezpe\u010dnos\u0165 alebo \u00fa\u010dinnos\u0165 tak\u00e9ho pr\u00edstupu.<\/p>\n

Pinealon vs Semax<\/h3>\n

Pinealon a Semax s\u00fa \u010dasto porovn\u00e1van\u00e9, preto\u017ee oboje boli sk\u00faman\u00e9 na neuroprotekciu a podporu kognit\u00edvnych funkci\u00ed. Napriek tomu patria do \u00faplne odli\u0161n\u00fdch rod\u00edn peptidov.<\/p>\n

Pinealon je kr\u00e1tky bioregula\u010dn\u00fd tripeptid (Glu-Asp-Arg), zatia\u013e \u010do Semax je syntetick\u00fd anal\u00f3g adrenokortikotropn\u00e9ho horm\u00f3nu ACTH(4-10), vyvinut\u00fd v Rusku na neurologick\u00e9 aplik\u00e1cie (9,10).<\/p>\n

Dostupn\u00e9 \u00fadaje nazna\u010duj\u00fa, \u017ee Pinealon uplat\u0148uje mnoho svojich biologick\u00fdch \u00fa\u010dinkov prostredn\u00edctvom regul\u00e1cie oxida\u010dn\u00e9ho stresu, epigenetick\u00fdch mechanizmov, modul\u00e1cie g\u00e9novej expresie, interakcie so serot\u00f3ninov\u00fdmi dr\u00e1hami a podpory pre\u017eitia neur\u00f3nov (4-8). Na druhej strane, v\u00fdskum Semaxu sa zameral predov\u0161etk\u00fdm na neurotrofick\u00fa aktivitu, modul\u00e1ciu neurotransmiterov\u00fdch syst\u00e9mov, neuroprotekciu po ischemick\u00fdch po\u0161kodeniach a zlep\u0161enie kognit\u00edvnych funkci\u00ed (9,10).<\/p>\n

Hoci oba tieto peptidy sa sk\u00famaj\u00fa pre zdravie mozgu a kognit\u00edvne funkcie, v\u00fdskum Semaxu prim\u00e1rne zd\u00f4raz\u0148uje neurotrofn\u00e9 \u00fa\u010dinky a \u00fa\u010dinky s\u00favisiace s neurotransmitermi, zatia\u013e \u010do v\u00fdskum Pinealonu sa zameriava viac na ochranu buniek, biol\u00f3giu starnutia, obmedzovanie oxida\u010dn\u00e9ho stresu a epigenetick\u00fa regul\u00e1ciu.<\/p>\n

V s\u00fa\u010dasnosti neboli uskuto\u010dnen\u00e9 priame klinick\u00e9 \u0161t\u00fadie porovn\u00e1vaj\u00face Pinealon a Semax u \u013eud\u00ed.<\/p>\n

Pinealon vs Cerebrolysin<\/h3>\n

Cerebrolysin sa v\u00fdrazne l\u00ed\u0161i od Pinealonu tak zlo\u017een\u00edm, ako aj komplexnos\u0165ou. Pinealon pozost\u00e1va z jedn\u00e9ho syntetick\u00e9ho tripeptidu, zatia\u013e \u010do Cerebrolysin je komplexn\u00e1 zmes n\u00edzkomolekul\u00e1rnych neuropeptidov a aminokyselinov\u00fdch fragmentov z\u00edskan\u00fdch z mozgov\u00e9ho tkaniva o\u0161\u00edpan\u00fdch.<\/p>\n

V\u00fdskum Cerebrolysinu sa s\u00fastredil predov\u0161etk\u00fdm na zotavenie po cievnej mozgovej pr\u00edhode, traumatickom poranen\u00ed mozgu, vaskul\u00e1rnej demencii a Alzheimerovej chorobe. Naopak, v\u00fdskum Pinealonu sa prim\u00e1rne zaoberal ochranou neur\u00f3nov, odolnos\u0165ou vo\u010di oxida\u010dn\u00e9mu stresu, kognit\u00edvnymi funkciami a zdrav\u00fdm starnut\u00edm (3 \u2013 8).<\/p>\n

Podstatn\u00fd rozdiel medzi t\u00fdmito zl\u00fa\u010deninami spo\u010d\u00edva v rozsahu dostupn\u00fdch klinick\u00fdch \u00fadajov. Cerebrolysin bol hodnoten\u00fd v ove\u013ea rozsiahlej\u0161\u00edch klinick\u00fdch \u0161t\u00fadi\u00e1ch ako Pinealon. \u00dadaje t\u00fdkaj\u00face sa Pinealonu s\u00fa st\u00e1le obmedzen\u00e9 a poch\u00e1dzaj\u00fa predov\u0161etk\u00fdm z predklinick\u00fdch \u0161t\u00fadi\u00ed a relat\u00edvne mal\u00fdch klinick\u00fdch sk\u00fa\u0161an\u00ed.<\/p>\n

Hoci obe zl\u00fa\u010deniny sa sk\u00famaj\u00fa pre svoje neuroprotekt\u00edvne vlastnosti, p\u00f4sobia odli\u0161n\u00fdmi biologick\u00fdmi mechanizmami a nemali by by\u0165 pova\u017eovan\u00e9 za zamenite\u013en\u00e9.<\/p>\n

Pinealon vs SS-31<\/h3>\n

SS-31 (elamipretide) je peptid zameran\u00fd na mitochondrie, vyvinut\u00fd na ochranu mitochondri\u00e1lnych funkci\u00ed a obmedzenie oxida\u010dn\u00e9ho po\u0161kodenia v bunk\u00e1ch. Na rozdiel od Pinealonu, ktor\u00fd sa zd\u00e1 ovplyv\u0148ova\u0165 g\u00e9nov\u00fa expresiu, pre\u017eitie neur\u00f3nov, synt\u00e9zu seroton\u00ednu a sign\u00e1lne dr\u00e1hy buniek, SS-31 p\u00f4sob\u00ed predov\u0161etk\u00fdm na mitochondri\u00e1lne membr\u00e1ny a bunkov\u00fa bioenergetiku.<\/p>\n

Oba peptidy boli sk\u00faman\u00e9 z h\u013eadiska ich schopnosti zni\u017eova\u0165 oxida\u010dn\u00fd stres. Uk\u00e1zalo sa, \u017ee Pinealon obmedzuje akumul\u00e1ciu reakt\u00edvnych foriem kysl\u00edka a zni\u017euje po\u0161kodenie buniek v podmienkach oxida\u010dn\u00e9ho stresu (4,5), zatia\u013e \u010do v\u00fdskum SS-31 sa zameral na zlep\u0161enie funk\u010dnosti mitochondri\u00ed a zn\u00ed\u017eenie po\u0161kodenia vypl\u00fdvaj\u00faceho z ich dysfunkcie.<\/p>\n

V s\u00fa\u010dasnosti neboli vykonan\u00e9 \u017eiadne priame \u0161t\u00fadie porovn\u00e1vaj\u00face Pinealon a SS-31.<\/p>\n

Pinealon vs Tesamorelin<\/h3>\n

Pinealon a Tesamorel\u00edn patria do \u00faplne odli\u0161n\u00fdch kateg\u00f3ri\u00ed peptidov a boli sk\u00faman\u00e9 na \u00faplne odli\u0161n\u00e9 biologick\u00e9 \u00fa\u010dely.<\/p>\n

Pinealon je bioregula\u010dn\u00fd neuroregula\u010dn\u00fd tripeptid, sk\u00faman\u00fd hlavne v kontexte neuroprotekcie, kognit\u00edvnych funkci\u00ed, regul\u00e1cie oxida\u010dn\u00e9ho stresu a zdrav\u00e9ho starnutia (3\u20138). Tesamorelin je anal\u00f3g horm\u00f3nu uvo\u013e\u0148uj\u00faceho rastov\u00fd horm\u00f3n (GHRH), ktor\u00fd stimuluje sekr\u00e9ciu endog\u00e9nneho rastov\u00e9ho horm\u00f3nu a zvy\u0161uje produkciu inzul\u00ednu podobn\u00e9ho rastov\u00e9ho faktora-1 (IGF-1).<\/p>\n

V\u00fdskum tesamorelinu sa prim\u00e1rne zameral na redukciu viscer\u00e1lneho tukov\u00e9ho tkaniva, zlo\u017eenie tela, metabolick\u00e9 zdravie a fyziol\u00f3giu s\u00favisiacu s rastov\u00fdm horm\u00f3nom. Na druhej strane, v\u00fdskum pinealonu sa zameral na ochranu neur\u00f3nov, procesy u\u010denia a pam\u00e4ti, expresiu seroton\u00ednu a bunkov\u00e9 mechanizmy s\u00favisiace so starnut\u00edm.<\/p>\n

Vzh\u013eadom na tieto v\u00fdznamn\u00e9 mechanick\u00e9 rozdiely \u201eTesamorelin alebo Pinealon?\u201d nie je priamym porovnan\u00edm. Oba peptidy s\u00fa v s\u00fa\u010dasnosti predmetom v\u00fdskumu pre r\u00f4zne vedeck\u00e9 \u00fa\u010dely a ovplyv\u0148uj\u00fa odli\u0161n\u00e9 fyziologick\u00e9 syst\u00e9my.<\/p>\n

V\u0161eobecn\u00fd vedeck\u00fd poh\u013ead<\/h2>\n

Pinealon vynik\u00e1 spomedzi mnoh\u00fdch \u010dasto diskutovan\u00fdch peptidov kombin\u00e1ciou neuroprotekt\u00edvnych, antioxida\u010dn\u00fdch, epigenetick\u00fdch a geroprotekt\u00edvnych vlastnost\u00ed. S\u00fa\u010dasn\u00e9 \u00fadaje nazna\u010duj\u00fa, \u017ee Pinealon m\u00f4\u017ee podporova\u0165 pre\u017eitie neur\u00f3nov, obmedzova\u0165 oxida\u010dn\u00fd stres, ovplyv\u0148ova\u0165 dr\u00e1hy s\u00favisiace so seroton\u00ednom a regulova\u0165 bunkov\u00e9 funkcie spojen\u00e9 so starnut\u00edm a neuroprotekciou.<\/p>\n

Priame klinick\u00e9 \u0161t\u00fadie porovn\u00e1vaj\u00face Pinealon s in\u00fdmi peptidmi zost\u00e1vaj\u00fa ve\u013emi obmedzen\u00e9. V d\u00f4sledku toho nie je mo\u017en\u00e9 v s\u00fa\u010dasnosti vyvodi\u0165 jednozna\u010dn\u00e9 z\u00e1very t\u00fdkaj\u00face sa relat\u00edvnej \u00fa\u010dinnosti, bezpe\u010dnosti alebo v\u00fdhod jednotliv\u00fdch zl\u00fa\u010den\u00edn. Na lep\u0161ie charakterizovanie podobnost\u00ed a rozdielov medzi t\u00fdmito peptidmi s\u00fa potrebn\u00e9 \u010fal\u0161ie, dobre navrhnut\u00e9 \u0161t\u00fadie na \u013eu\u010foch.<\/p>\n

Zrieknutie sa zodpovednosti<\/h3>\n

Obsah je ur\u010den\u00fd v\u00fdlu\u010dne na vzdel\u00e1vacie a informa\u010dn\u00e9 \u00fa\u010dely a nemal by by\u0165 interpretovan\u00fd ako lek\u00e1rska rada, diagn\u00f3za, lie\u010dba ani odborn\u00e9 odpor\u00fa\u010danie. Pinealon, Epitalon, Semax, Cerebrolysin, SS-31 a Tesam \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03bf sa v\u00fdznamne l\u00ed\u0161ia z h\u013eadiska \u0161trukt\u00fary, mechanizmu \u00fa\u010dinku a oblast\u00ed vedeck\u00e9ho v\u00fdskumu. Pinealon nebol schv\u00e1len\u00fd americk\u00fdm \u00daradom pre kontrolu potrav\u00edn a lie\u010div (FDA), Eur\u00f3pskou liekovou agent\u00farou (EMA) ani v\u00e4\u010d\u0161inou in\u00fdch regula\u010dn\u00fdch org\u00e1nov na lie\u010dbu neurologick\u00fdch por\u00fach, kognit\u00edvnych por\u00fach, probl\u00e9mov s\u00favisiacich so starnut\u00edm alebo ak\u00fdchko\u013evek in\u00fdch lek\u00e1rskych indik\u00e1ci\u00ed. Zna\u010dn\u00e1 \u010das\u0165 dostupn\u00fdch \u00fadajov poch\u00e1dza z predklinick\u00fdch \u0161t\u00fadi\u00ed a obmedzen\u00fdch \u0161t\u00fadi\u00ed na \u013eu\u010foch. Na lep\u0161ie ur\u010denie \u00fa\u010dinnosti, bezpe\u010dnosti a dlhodob\u00fdch \u00fa\u010dinkov t\u00fdchto peptidov ako aj na zistenie, \u010di medzi nimi existuj\u00fa v\u00fdznamn\u00e9 rozdiely v klinick\u00fdch podmienkach, s\u00fa potrebn\u00e9 \u010fal\u0161ie, dobre navrhnut\u00e9 klinick\u00e9 \u0161t\u00fadie.<\/p>\n

Odkazy<\/h4>\n
    \n
  1. Ch\u00e9mia a zlo\u017eenie podataka Pinealon (EDR peptid).<\/span>
    Wikip\u00e9dia https:\/\/en.wikipedia.org\/wiki\/Pinealon<\/a><\/span><\/li>\n
  2. Fedoreyeva, L. I., Kireev, I. I., Khavinson, V. K., & Vanyushin, B. F. (2011). Penetr\u00e1cia kr\u00e1tkych fluorescen\u010dne zna\u010den\u00fdch peptidov do jadra v bunk\u00e1ch HeLa a in vitro \u0161pecifick\u00e1 interakcia peptidov s deoxyribooligonucleotidmi a DNA<\/em>. Bioch\u00e9mia (Moskva), 76<\/em>(11), 1210\u20131219. https:\/\/doi.org\/10.1134\/S0006297911110022<\/a><\/span>
    Odkaz na \u010dasopis:     https:\/\/link.springer.com\/article\/10.1134\/S0006297911110022<\/a><\/span><\/li>\n
  3. Meshchaninov, V. N., Tkachenko, E. L., Zharkov, S. V., Gavrilov, I. V., & Katyreva, Y. E. (2015). Vplyv syntetick\u00fdch peptidov na starnutie pacientov s chronickou polymorbiditou a syndr\u00f3mom organick\u00e9ho po\u0161kodenia centr\u00e1lnej nervovej s\u00fastavy v remisii<\/em>. Pokroky v gerontol\u00f3gii, 28<\/em>(1), 62\u201367.<\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/26390612\/<\/a><\/span><\/li>\n
  4. Khavinson, V., Ribakova, Y., a kol. (2011). Pinealon zvy\u0161uje \u017eivotaschopnos\u0165 buniek potla\u010den\u00edm hladiny vo\u013en\u00fdch radik\u00e1lov a aktiv\u00e1ciou proliferat\u00edvnych procesov<\/em>. V\u00fdskum omladzovania, 14<\/em>(5), 517\u2013523. https:\/\/doi.org\/10.1089\/rej.2011.1172<\/a><\/span>
    Odkaz na \u010dasopis:     https:\/\/journals.sagepub.com\/doi\/abs\/10.1089\/rej.2011.1172<\/a><\/span><\/li>\n
  5. Arutjunjan, A. V., Kozina, L. S., Stvolinsk\u00fd, S. L., Bulyginov\u00e1, E. R., Ma\u0161kinov\u00e1, A. P., & Chavinsson, V. K. (2012). Pinealon chr\u00e1ni potkanie potomstvo pred prenat\u00e1lnou hyperhomocystein\u00e9miou<\/em>. Medzin\u00e1rodn\u00fd \u010dasopis o peptidoch, 2012<\/em>, 109757. https:\/\/doi.org\/10.1155\/2012\/109757<\/a><\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/22567179\/<\/a><\/span>
    Cel\u00fd text PMC:     https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3342713\/<\/a><\/span><\/li>\n
  6. Khavinson, V. K., Lin\u2019kova, N. S., Tarnovskaya, S. I., Umnov, R. S., Elashkina, E. V., & Durnova, A. O. (2014). Kr\u00e1tke peptidy stimuluj\u00fa expresiu s\u00e9roton\u00ednu v bunk\u00e1ch mozgovej k\u00f4ry<\/em>. Bulletin experiment\u00e1lnej biol\u00f3gie a medic\u00edny, 157<\/em>(1), 77\u201380. https:\/\/doi.org\/10.1007\/s10517-014-2496-y<\/a><\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/24909721\/<\/a><\/span><\/li>\n
  7. Kraskovskaya, N. A., Kukanova, E. O., Lin\u2019kova, N. S., Popugaeva, E. A., & Khavinson, V. K. (2017). Tripeptidy obnovuj\u00fa po\u010det neuron\u00e1lnych t\u0155\u0148ov in vitro v podmienkach modelov\u00e9ho Alzheimerovej choroby.<\/em>. Bulletin experiment\u00e1lnej biol\u00f3gie a medic\u00edny, 163<\/em>(4), 547\u2013550. https:\/\/doi.org\/10.1007\/s10517-017-3847-2<\/a><\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/28853087\/<\/a><\/span><\/li>\n
  8. Khavinson, V., Ilina, A., Kraskovskaya, N., Linkova, N., Kolchina, N., Mironova, E., Erofeev, A., & Petukhov, M. (2021). Neuroprotekt\u00edvne \u00fa\u010dinky tripeptidov \u2013 epigenetick\u00fdch regul\u00e1torov na my\u0161om modeli Alzheimerovej choroby<\/em>. Farmaceutik\u00e1, 14<\/em>(6), 515. https:\/\/doi.org\/10.3390\/ph14060515<\/a><\/span>
    Odkaz na \u010dasopis:     https:\/\/www.mdpi.com\/1424-8247\/14\/6\/515<\/a><\/span><\/li>\n
  9. Tsai, S. J. (2007). Semax, anal\u00f3g adrenokortikotrop\u00ednu (4\u201310), je potenci\u00e1lny liek na lie\u010dbu poruchy pozornosti s hyperaktivitou a Rettovho syndr\u00f3mu.<\/em>. Medical Hypotheses, 68<\/em>(5), 1144\u20131146. https:\/\/doi.org\/10.1016\/j.mehy.2006.07.017<\/a><\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/16996699\/<\/a><\/span><\/li>\n
  10. Dolotov, O. V., Karpenko, E. A., Inozemtseva, L. S., Seredenina, T. S., Levitskaya, N. G., Rozyczka, J., Dubynina, E. V., Novosadova, E. V., Andreeva, L. A., Alfeeva, L. Y., Kamensky, A. A., Grivennikov, I. A., Myasoedov, N. F., & Engele, J. (2006). Semax, anal\u00f3g ACTH(4-10) s kognit\u00edvnymi \u00fa\u010dinkami, reguluje expresiu BDNF a trkB v hipokampe potkana<\/em>. V\u00fdskum mozgu, 1117<\/em>(1), 54\u201360. https:\/\/doi.org\/10.1016\/j.brainres.2006.07.108<\/a><\/span>
    PubMed:     https:\/\/pubmed.ncbi.nlm.nih.gov\/16996037\/<\/a><\/span><\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"

      Pinealon a \u010fal\u0161ie peptydy S rast\u00facim z\u00e1ujmom o intervencie zalo\u017een\u00e9 na peptidoch sa Pinealon \u010dasto porovn\u00e1va s nieko\u013ek\u00fdmi zn\u00e1mymi peptidmi, vr\u00e1tane Epitalonu, Semaxu,\u2026<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[253],"tags":[],"class_list":["post-51179","post","type-post","status-publish","format-standard","hentry","category-kategoria-pinealon","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/posts\/51179","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/comments?post=51179"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/posts\/51179\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/media?parent=51179"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/categories?post=51179"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/tags?post=51179"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}